Cargando…
How to select a best-value biological medicine? A practical model to support hospital pharmacists
PURPOSE: With the growing availability of biosimilars on the global market, clinicians and pharmacists have multiple off-patent biological products to choose from. Besides the competitiveness of the product’s price, other criteria should be considered when selecting a best-value biological. This art...
Autores principales: | Barbier, Liese, Vandenplas, Yannick, Boone, Niels, Huys, Isabelle, Janknegt, Rob, Vulto, Arnold G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452170/ https://www.ncbi.nlm.nih.gov/pubmed/36002245 http://dx.doi.org/10.1093/ajhp/zxac235 |
Ejemplares similares
-
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians
por: Barbier, Liese, et al.
Publicado: (2021) -
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines
por: Vandenplas, Yannick, et al.
Publicado: (2022) -
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
por: Vandenplas, Yannick, et al.
Publicado: (2022) -
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
por: Vandenplas, Yannick, et al.
Publicado: (2021) -
Off-Patent Biologicals and Biosimilars Tendering in Europe—A Proposal towards More Sustainable Practices
por: Barbier, Liese, et al.
Publicado: (2021)